Respiratory Disorders (DBCOND0036814)

Identifiers

Synonyms

Respiratory disorder / Respiratory disorder, unspecified / Respiration Disorders / Unspecified disease of respiratory system / Disease of respiratory system (disorder) / Respiratory disorder NOS / Respiratory system disorder

Associated Data

Indicated Drugs and Targets

Drug	Description	Targets
Clonazoline	Not Annotated	No drug targets
Oxygen	An essential element for human survival used in clinical conditions in which there is a lack of oxygen, such as, but not limited to, anoxia, hypoxia or dyspnea.	NADPH oxidase 1target Cytochrome c oxidase subunit 1target Hemoglobin subunit betacarrier Hemoglobin subunit alphacarrier
Sobrerol	A mucolytic indicated in patients with chronic respiratory diseases.	No drug targets

Clinical Trials

Identifier	Title	Drug(s)	Purpose	Phase	Status
NCT05973201	Evaluation of Virtual Reality to Reduce Anxiety, Pain and Duration of Non-emergency Vigile Bronchial Fibroscopy (AVATAR)	No drug interventions	supportive_care	Not Available	recruiting
NCT03596541	Clinical Validation of Tele-stethoscope System Digital	No drug interventions	health_services_research	Not Available	completed
NCT04678856	Dupilumab in CRSsNP	Dupilumab	treatment	2	completed
NCT06237322	Study of RE.DOCTOR Vitals® Software Accuracy	No drug interventions	Not Available	Not Available	not_yet_recruiting
NCT04763746	The Measurement of VItal SIgns by Lifelight® Software in comparisON to the Standard of Care - Multi-site Development	No drug interventions	Not Available	Not Available	completed
NCT02316379	Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration	Xenon	diagnostic	1 / 2	recruiting
NCT03557645	Ventilator Hyperinflation and Hemodynamics	No drug interventions	treatment	Not Available	completed
NCT02322671	Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects	Montelukast	treatment	1	completed
NCT01587807	A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057	No drug interventions	other	1	completed
NCT02272049	Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults	Xenon	diagnostic	1 / 2	recruiting
NCT02075541	A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction.	No drug interventions	prevention	2	completed
NCT01818024	A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers	No drug interventions	treatment	1	completed
NCT00844935	Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients	No drug interventions	Not Available	Not Available	withdrawn
NCT03443427	A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine	No drug interventions	prevention	2	completed
NCT01395862	Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)	Fluticasone Salmeterol	Not Available	Not Available	completed
NCT03894969	Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine	Human varicella-zoster immune globulin Varicella zoster vaccine (recombinant)	prevention	2	completed
NCT03151395	Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific	No drug interventions	basic_science	Not Available	completed
NCT00835003	Timing of Planned Caesarean Section and Morbidity of the Newborn	No drug interventions	prevention	Not Available	completed
NCT01678677	A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers	No drug interventions	prevention	1	completed
NCT01443845	Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS)	Roflumilast	treatment	4	completed
NCT01360398	Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly	No drug interventions	basic_science	Not Available	completed
NCT03201211	A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults	No drug interventions	prevention	1	completed
NCT01505556	Proprioceptive Postural Control and Diaphragm Paresis	No drug interventions	Not Available	Not Available	withdrawn
NCT01516437	A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD	No drug interventions	basic_science	Not Available	completed
NCT01395849	Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)	Fluticasone Salmeterol	Not Available	Not Available	completed
NCT02658422	Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions	Montelukast	basic_science	1	completed
NCT01657526	Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine	No drug interventions	prevention	1	completed
NCT02547974	A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults.	No drug interventions	prevention	1	completed
NCT01505582	Inspiratory Muscle Training and Low Back Pain	No drug interventions	treatment	Not Available	completed
NCT03281876	A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response.	No drug interventions	prevention	2	completed
NCT00455767	Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients	No drug interventions	treatment	2	completed
NCT01476046	Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects.	No drug interventions	diagnostic	1	completed